Novartis Ag (NVS) Revenue (2009 - 2026)

Novartis Ag has disclosed Revenue across 18 years of filings, most recently posting $14.4 billion for Q2 2026.

• In Q2 2026, Revenue rose 2.52% year-over-year to $14.4 billion; the TTM figure through Jun 2026 stood at $68.7 billion (down 11.07% YoY), while the FY2025 annual figure was $54.5 billion, up 8.38% from the prior year.
• Revenue came in at $14.4 billion for Q2 2026 at Novartis Ag, up from $13.1 billion in the prior quarter.
• In the past five years, Revenue ranged from a high of $37.2 billion in Q4 2024 to a low of $10.5 billion in Q3 2022.
• Average Revenue over 5 years is $17.0 billion, with a median of $13.0 billion recorded in 2024.
• Year-over-year, Revenue rose 24.69% in 2022 and fell 26.58% in 2025.
• Over 5 years, Revenue stood at $31.6 billion in 2022, then climbed by 7.55% to $34.0 billion in 2023, then gained by 9.25% to $37.2 billion in 2024, then decreased by 26.58% to $27.3 billion in 2025, then tumbled by 47.2% to $14.4 billion in 2026.
• Per Business Quant data, the three most recent Revenue figures were $14.4 billion in Q2 2026, $13.1 billion in Q1 2026, and $27.3 billion in Q4 2025.